Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 4 | $475,266 |
Sells | 124 | $9,441,166 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
16 Dec 2022 16:55 | TARS | Tarsus Pharmaceuticals Inc | GREENSTEIN LEONARD M. | Chief Financial Officer | 15 Dec 2022 | Sale | 5,000 | 14.64 | 73,200 | D |
16 Dec 2022 16:51 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 14 Dec 2022 | Sale | 6,420 | 15.08 | 96,814 | I |
06 Dec 2022 17:52 | TARS | Tarsus Pharmaceuticals Inc | WHITFIELD DIANNE C. | Chief Human Resources Officer | 02 Dec 2022 | Sale | 1,154 | 16.9 | 19,503 | D |
06 Dec 2022 17:49 | TARS | Tarsus Pharmaceuticals Inc | WAHL BRYAN | General Counsel | 02 Dec 2022 | Sale | 1,154 | 16.9 | 19,503 | D |
01 Dec 2022 20:09 | TARS | Tarsus Pharmaceuticals Inc | WHITFIELD DIANNE C. | Chief Human Resources Officer | 01 Dec 2022 | Sale | 1,165 | 16.75 | 19,514 | D |
01 Dec 2022 20:09 | TARS | Tarsus Pharmaceuticals Inc | WHITFIELD DIANNE C. | Chief Human Resources Officer | 30 Nov 2022 | Sale | 1,182 | 16.5 | 19,503 | D |
01 Dec 2022 19:58 | TARS | Tarsus Pharmaceuticals Inc | WAHL BRYAN | General Counsel | 01 Dec 2022 | Sale | 1,164 | 16.75 | 19,497 | D |
01 Dec 2022 19:58 | TARS | Tarsus Pharmaceuticals Inc | WAHL BRYAN | General Counsel | 30 Nov 2022 | Sale | 1,183 | 16.5 | 19,520 | D |
18 Nov 2022 16:12 | TARS | Tarsus Pharmaceuticals Inc | GREENSTEIN LEONARD M. | Chief Financial Officer | 17 Nov 2022 | Sale | 5,000 | 16.54 | 82,700 | D |
18 Nov 2022 16:09 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President and CEO | 16 Nov 2022 | Sale | 745 | 17.31 | 12,896 | I |
18 Nov 2022 16:09 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President and CEO | 16 Nov 2022 | Sale | 7,255 | 16.81 | 121,957 | I |
17 Nov 2022 17:30 | TARS | Tarsus Pharmaceuticals Inc | MOTTIWALA AZIZ | Chief Commercial Officer | 15 Nov 2022 | Sale | 6,857 | 17.72 | 121,506 | D |
14 Nov 2022 16:25 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President and CEO | 09 Nov 2022 | Sale | 9,000 | 17.87 | 160,830 | I |
28 Oct 2022 16:24 | TARS | Tarsus Pharmaceuticals Inc | GREENSTEIN LEONARD M. | Chief Financial Officer | 20 Oct 2022 | Sale | 123 | 16.62 | 2,044 | D |
28 Oct 2022 16:24 | TARS | Tarsus Pharmaceuticals Inc | GREENSTEIN LEONARD M. | Chief Financial Officer | 20 Oct 2022 | Sale | 4,877 | 15.9 | 77,544 | D |
21 Oct 2022 16:23 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President and CEO | 19 Oct 2022 | Sale | 100 | 17.6 | 1,760 | I |
21 Oct 2022 16:23 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President and CEO | 19 Oct 2022 | Sale | 7,900 | 16.91 | 133,589 | I |
14 Oct 2022 16:32 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President and CEO | 12 Oct 2022 | Sale | 2,821 | 16.24 | 45,813 | I |
14 Oct 2022 16:32 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President and CEO | 12 Oct 2022 | Sale | 6,179 | 15.76 | 97,381 | I |
23 Sep 2022 18:08 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President and CEO | 21 Sep 2022 | Sale | 100 | 17.045 | 1,705 | I |
23 Sep 2022 18:08 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President and CEO | 21 Sep 2022 | Sale | 7,900 | 16.3 | 128,770 | I |
16 Sep 2022 16:33 | TARS | Tarsus Pharmaceuticals Inc | GREENSTEIN LEONARD M. | Chief Financial Officer | 15 Sep 2022 | Sale | 5,000 | 16.03 | 80,150 | D |
16 Sep 2022 16:28 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President and CEO | 14 Sep 2022 | Sale | 9,000 | 16.01 | 144,090 | I |
16 Sep 2022 16:24 | TARS | Tarsus Pharmaceuticals Inc | LIN ELIZABETH YEU | Director | 14 Sep 2022 | Purchase | 6,360 | 16.29 | 103,604 | I |
16 Sep 2022 16:24 | TARS | Tarsus Pharmaceuticals Inc | LIN ELIZABETH YEU | Director | 14 Sep 2022 | Purchase | 12,040 | 16.03 | 193,001 | I |
19 Aug 2022 16:52 | TARS | Tarsus Pharmaceuticals Inc | GREENSTEIN LEONARD M. | Chief Financial Officer | 18 Aug 2022 | Sale | 5,000 | 16.3 | 81,500 | D |
19 Aug 2022 16:49 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President and CEO | 17 Aug 2022 | Sale | 736 | 17.44 | 12,836 | I |
19 Aug 2022 16:49 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President and CEO | 17 Aug 2022 | Sale | 7,264 | 16.5 | 119,856 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)